Request for Covid-19 Impact Assessment of this Report
The United States Amifampridine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Amifampridine market, reaching US$ million by the year 2028. As for the Europe Amifampridine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Amifampridine players cover Jacobus Pharmaceutical, Unichem, BioMarin Pharmaceutical, and Wockhardt, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Amifampridine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Generic
Patent
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Myasthenia Gravis
Potassium Channel Blocker
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Jacobus Pharmaceutical
Unichem
BioMarin Pharmaceutical
Wockhardt
Glenmark Pharmaceuticals
Norris Pharm
BLD Pharm
Biosynth AG
Innovapharm
Founder Pharma
BroadPharm
CSNpharm
Merck
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amifampridine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Amifampridine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Amifampridine by Country/Region, 2017, 2022 & 2028
2.2 Amifampridine Segment by Type
2.2.1 Generic
2.2.2 Patent
2.3 Amifampridine Sales by Type
2.3.1 Global Amifampridine Sales Market Share by Type (2017-2022)
2.3.2 Global Amifampridine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Amifampridine Sale Price by Type (2017-2022)
2.4 Amifampridine Segment by Application
2.4.1 Myasthenia Gravis
2.4.2 Potassium Channel Blocker
2.5 Amifampridine Sales by Application
2.5.1 Global Amifampridine Sale Market Share by Application (2017-2022)
2.5.2 Global Amifampridine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Amifampridine Sale Price by Application (2017-2022)
3 Global Amifampridine by Company
3.1 Global Amifampridine Breakdown Data by Company
3.1.1 Global Amifampridine Annual Sales by Company (2020-2022)
3.1.2 Global Amifampridine Sales Market Share by Company (2020-2022)
3.2 Global Amifampridine Annual Revenue by Company (2020-2022)
3.2.1 Global Amifampridine Revenue by Company (2020-2022)
3.2.2 Global Amifampridine Revenue Market Share by Company (2020-2022)
3.3 Global Amifampridine Sale Price by Company
3.4 Key Manufacturers Amifampridine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amifampridine Product Location Distribution
3.4.2 Players Amifampridine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Amifampridine by Geographic Region
4.1 World Historic Amifampridine Market Size by Geographic Region (2017-2022)
4.1.1 Global Amifampridine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Amifampridine Annual Revenue by Geographic Region
4.2 World Historic Amifampridine Market Size by Country/Region (2017-2022)
4.2.1 Global Amifampridine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Amifampridine Annual Revenue by Country/Region
4.3 Americas Amifampridine Sales Growth
4.4 APAC Amifampridine Sales Growth
4.5 Europe Amifampridine Sales Growth
4.6 Middle East & Africa Amifampridine Sales Growth
5 Americas
5.1 Americas Amifampridine Sales by Country
5.1.1 Americas Amifampridine Sales by Country (2017-2022)
5.1.2 Americas Amifampridine Revenue by Country (2017-2022)
5.2 Americas Amifampridine Sales by Type
5.3 Americas Amifampridine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amifampridine Sales by Region
6.1.1 APAC Amifampridine Sales by Region (2017-2022)
6.1.2 APAC Amifampridine Revenue by Region (2017-2022)
6.2 APAC Amifampridine Sales by Type
6.3 APAC Amifampridine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Amifampridine by Country
7.1.1 Europe Amifampridine Sales by Country (2017-2022)
7.1.2 Europe Amifampridine Revenue by Country (2017-2022)
7.2 Europe Amifampridine Sales by Type
7.3 Europe Amifampridine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Amifampridine by Country
8.1.1 Middle East & Africa Amifampridine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Amifampridine Revenue by Country (2017-2022)
8.2 Middle East & Africa Amifampridine Sales by Type
8.3 Middle East & Africa Amifampridine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amifampridine
10.3 Manufacturing Process Analysis of Amifampridine
10.4 Industry Chain Structure of Amifampridine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amifampridine Distributors
11.3 Amifampridine Customer
12 World Forecast Review for Amifampridine by Geographic Region
12.1 Global Amifampridine Market Size Forecast by Region
12.1.1 Global Amifampridine Forecast by Region (2023-2028)
12.1.2 Global Amifampridine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amifampridine Forecast by Type
12.7 Global Amifampridine Forecast by Application
13 Key Players Analysis
13.1 Jacobus Pharmaceutical
13.1.1 Jacobus Pharmaceutical Company Information
13.1.2 Jacobus Pharmaceutical Amifampridine Product Offered
13.1.3 Jacobus Pharmaceutical Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Jacobus Pharmaceutical Main Business Overview
13.1.5 Jacobus Pharmaceutical Latest Developments
13.2 Unichem
13.2.1 Unichem Company Information
13.2.2 Unichem Amifampridine Product Offered
13.2.3 Unichem Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Unichem Main Business Overview
13.2.5 Unichem Latest Developments
13.3 BioMarin Pharmaceutical
13.3.1 BioMarin Pharmaceutical Company Information
13.3.2 BioMarin Pharmaceutical Amifampridine Product Offered
13.3.3 BioMarin Pharmaceutical Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BioMarin Pharmaceutical Main Business Overview
13.3.5 BioMarin Pharmaceutical Latest Developments
13.4 Wockhardt
13.4.1 Wockhardt Company Information
13.4.2 Wockhardt Amifampridine Product Offered
13.4.3 Wockhardt Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Wockhardt Main Business Overview
13.4.5 Wockhardt Latest Developments
13.5 Glenmark Pharmaceuticals
13.5.1 Glenmark Pharmaceuticals Company Information
13.5.2 Glenmark Pharmaceuticals Amifampridine Product Offered
13.5.3 Glenmark Pharmaceuticals Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Glenmark Pharmaceuticals Main Business Overview
13.5.5 Glenmark Pharmaceuticals Latest Developments
13.6 Norris Pharm
13.6.1 Norris Pharm Company Information
13.6.2 Norris Pharm Amifampridine Product Offered
13.6.3 Norris Pharm Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Norris Pharm Main Business Overview
13.6.5 Norris Pharm Latest Developments
13.7 BLD Pharm
13.7.1 BLD Pharm Company Information
13.7.2 BLD Pharm Amifampridine Product Offered
13.7.3 BLD Pharm Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 BLD Pharm Main Business Overview
13.7.5 BLD Pharm Latest Developments
13.8 Biosynth AG
13.8.1 Biosynth AG Company Information
13.8.2 Biosynth AG Amifampridine Product Offered
13.8.3 Biosynth AG Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Biosynth AG Main Business Overview
13.8.5 Biosynth AG Latest Developments
13.9 Innovapharm
13.9.1 Innovapharm Company Information
13.9.2 Innovapharm Amifampridine Product Offered
13.9.3 Innovapharm Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Innovapharm Main Business Overview
13.9.5 Innovapharm Latest Developments
13.10 Founder Pharma
13.10.1 Founder Pharma Company Information
13.10.2 Founder Pharma Amifampridine Product Offered
13.10.3 Founder Pharma Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Founder Pharma Main Business Overview
13.10.5 Founder Pharma Latest Developments
13.11 BroadPharm
13.11.1 BroadPharm Company Information
13.11.2 BroadPharm Amifampridine Product Offered
13.11.3 BroadPharm Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 BroadPharm Main Business Overview
13.11.5 BroadPharm Latest Developments
13.12 CSNpharm
13.12.1 CSNpharm Company Information
13.12.2 CSNpharm Amifampridine Product Offered
13.12.3 CSNpharm Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 CSNpharm Main Business Overview
13.12.5 CSNpharm Latest Developments
13.13 Merck
13.13.1 Merck Company Information
13.13.2 Merck Amifampridine Product Offered
13.13.3 Merck Amifampridine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Merck Main Business Overview
13.13.5 Merck Latest Developments
14 Research Findings and Conclusion
Table 1. Amifampridine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Amifampridine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Generic
Table 4. Major Players of Patent
Table 5. Global Amifampridine Sales by Type (2017-2022) & (K Units)
Table 6. Global Amifampridine Sales Market Share by Type (2017-2022)
Table 7. Global Amifampridine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Amifampridine Revenue Market Share by Type (2017-2022)
Table 9. Global Amifampridine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Amifampridine Sales by Application (2017-2022) & (K Units)
Table 11. Global Amifampridine Sales Market Share by Application (2017-2022)
Table 12. Global Amifampridine Revenue by Application (2017-2022)
Table 13. Global Amifampridine Revenue Market Share by Application (2017-2022)
Table 14. Global Amifampridine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Amifampridine Sales by Company (2020-2022) & (K Units)
Table 16. Global Amifampridine Sales Market Share by Company (2020-2022)
Table 17. Global Amifampridine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Amifampridine Revenue Market Share by Company (2020-2022)
Table 19. Global Amifampridine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Amifampridine Producing Area Distribution and Sales Area
Table 21. Players Amifampridine Products Offered
Table 22. Amifampridine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Amifampridine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Amifampridine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Amifampridine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Amifampridine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Amifampridine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Amifampridine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Amifampridine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Amifampridine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Amifampridine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Amifampridine Sales Market Share by Country (2017-2022)
Table 35. Americas Amifampridine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Amifampridine Revenue Market Share by Country (2017-2022)
Table 37. Americas Amifampridine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Amifampridine Sales Market Share by Type (2017-2022)
Table 39. Americas Amifampridine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Amifampridine Sales Market Share by Application (2017-2022)
Table 41. APAC Amifampridine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Amifampridine Sales Market Share by Region (2017-2022)
Table 43. APAC Amifampridine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Amifampridine Revenue Market Share by Region (2017-2022)
Table 45. APAC Amifampridine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Amifampridine Sales Market Share by Type (2017-2022)
Table 47. APAC Amifampridine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Amifampridine Sales Market Share by Application (2017-2022)
Table 49. Europe Amifampridine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Amifampridine Sales Market Share by Country (2017-2022)
Table 51. Europe Amifampridine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Amifampridine Revenue Market Share by Country (2017-2022)
Table 53. Europe Amifampridine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Amifampridine Sales Market Share by Type (2017-2022)
Table 55. Europe Amifampridine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Amifampridine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Amifampridine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Amifampridine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Amifampridine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Amifampridine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Amifampridine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Amifampridine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Amifampridine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Amifampridine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Amifampridine
Table 66. Key Market Challenges & Risks of Amifampridine
Table 67. Key Industry Trends of Amifampridine
Table 68. Amifampridine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Amifampridine Distributors List
Table 71. Amifampridine Customer List
Table 72. Global Amifampridine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Amifampridine Sales Market Forecast by Region
Table 74. Global Amifampridine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Amifampridine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Amifampridine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Amifampridine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Amifampridine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Amifampridine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Amifampridine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Amifampridine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Amifampridine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Amifampridine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Amifampridine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Amifampridine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Amifampridine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Amifampridine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Amifampridine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Amifampridine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Amifampridine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Amifampridine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Jacobus Pharmaceutical Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 93. Jacobus Pharmaceutical Amifampridine Product Offered
Table 94. Jacobus Pharmaceutical Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Jacobus Pharmaceutical Main Business
Table 96. Jacobus Pharmaceutical Latest Developments
Table 97. Unichem Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 98. Unichem Amifampridine Product Offered
Table 99. Unichem Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Unichem Main Business
Table 101. Unichem Latest Developments
Table 102. BioMarin Pharmaceutical Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 103. BioMarin Pharmaceutical Amifampridine Product Offered
Table 104. BioMarin Pharmaceutical Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. BioMarin Pharmaceutical Main Business
Table 106. BioMarin Pharmaceutical Latest Developments
Table 107. Wockhardt Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 108. Wockhardt Amifampridine Product Offered
Table 109. Wockhardt Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Wockhardt Main Business
Table 111. Wockhardt Latest Developments
Table 112. Glenmark Pharmaceuticals Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 113. Glenmark Pharmaceuticals Amifampridine Product Offered
Table 114. Glenmark Pharmaceuticals Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Glenmark Pharmaceuticals Main Business
Table 116. Glenmark Pharmaceuticals Latest Developments
Table 117. Norris Pharm Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 118. Norris Pharm Amifampridine Product Offered
Table 119. Norris Pharm Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Norris Pharm Main Business
Table 121. Norris Pharm Latest Developments
Table 122. BLD Pharm Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 123. BLD Pharm Amifampridine Product Offered
Table 124. BLD Pharm Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. BLD Pharm Main Business
Table 126. BLD Pharm Latest Developments
Table 127. Biosynth AG Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 128. Biosynth AG Amifampridine Product Offered
Table 129. Biosynth AG Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Biosynth AG Main Business
Table 131. Biosynth AG Latest Developments
Table 132. Innovapharm Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 133. Innovapharm Amifampridine Product Offered
Table 134. Innovapharm Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Innovapharm Main Business
Table 136. Innovapharm Latest Developments
Table 137. Founder Pharma Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 138. Founder Pharma Amifampridine Product Offered
Table 139. Founder Pharma Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Founder Pharma Main Business
Table 141. Founder Pharma Latest Developments
Table 142. BroadPharm Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 143. BroadPharm Amifampridine Product Offered
Table 144. BroadPharm Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. BroadPharm Main Business
Table 146. BroadPharm Latest Developments
Table 147. CSNpharm Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 148. CSNpharm Amifampridine Product Offered
Table 149. CSNpharm Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. CSNpharm Main Business
Table 151. CSNpharm Latest Developments
Table 152. Merck Basic Information, Amifampridine Manufacturing Base, Sales Area and Its Competitors
Table 153. Merck Amifampridine Product Offered
Table 154. Merck Amifampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Merck Main Business
Table 156. Merck Latest Developments
List of Figures
Figure 1. Picture of Amifampridine
Figure 2. Amifampridine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amifampridine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Amifampridine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Amifampridine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Generic
Figure 10. Product Picture of Patent
Figure 11. Global Amifampridine Sales Market Share by Type in 2021
Figure 12. Global Amifampridine Revenue Market Share by Type (2017-2022)
Figure 13. Amifampridine Consumed in Myasthenia Gravis
Figure 14. Global Amifampridine Market: Myasthenia Gravis (2017-2022) & (K Units)
Figure 15. Amifampridine Consumed in Potassium Channel Blocker
Figure 16. Global Amifampridine Market: Potassium Channel Blocker (2017-2022) & (K Units)
Figure 17. Global Amifampridine Sales Market Share by Application (2017-2022)
Figure 18. Global Amifampridine Revenue Market Share by Application in 2021
Figure 19. Amifampridine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Amifampridine Revenue Market Share by Company in 2021
Figure 21. Global Amifampridine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Amifampridine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Amifampridine Sales Market Share by Region (2017-2022)
Figure 24. Global Amifampridine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Amifampridine Sales 2017-2022 (K Units)
Figure 26. Americas Amifampridine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Amifampridine Sales 2017-2022 (K Units)
Figure 28. APAC Amifampridine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Amifampridine Sales 2017-2022 (K Units)
Figure 30. Europe Amifampridine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Amifampridine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Amifampridine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Amifampridine Sales Market Share by Country in 2021
Figure 34. Americas Amifampridine Revenue Market Share by Country in 2021
Figure 35. United States Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Amifampridine Sales Market Share by Region in 2021
Figure 40. APAC Amifampridine Revenue Market Share by Regions in 2021
Figure 41. China Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Amifampridine Sales Market Share by Country in 2021
Figure 48. Europe Amifampridine Revenue Market Share by Country in 2021
Figure 49. Germany Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Amifampridine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Amifampridine Revenue Market Share by Country in 2021
Figure 56. Egypt Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Amifampridine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Amifampridine in 2021
Figure 62. Manufacturing Process Analysis of Amifampridine
Figure 63. Industry Chain Structure of Amifampridine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...